Nexgel (NXGLW) Share-based Compensation (2019 - 2025)
Nexgel's (NXGLW) quarterly Share-based Compensation came in at -$23000.0 in Q4 2025, down 123.96% YoY from $96000.0 in Q4 2024, and down 106.01% on a QoQ basis from $383000.0 in Q3 2025.
Nexgel (NXGLW) Share-based Compensation (2019 - 2025) Analysis & Trends
Nexgel (NXGLW) has 7 years of Share-based Compensation data on file, last reported at -$23000.0 in Q4 2025.
- Quarterly Share-based Compensation fell 123.96% year-over-year to -$23000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $224000.0 (down 28.66% YoY) and the FY2025 annual result came in at $609000.0, up 65.94% from the prior year.
- Share-based Compensation slipped to -$23000.0 in Q4 2025, from $383000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $715000.0 in Q1 2025 to a low of -$23000.0 in Q4 2025.
- A 5-year average of $167944.4 and a median of $85000.0 in 2022 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 1224.07% in 2025, down 123.96% in 2025.
- Tracing NXGLW's Share-based Compensation over 5 years: stood at $56000.0 in 2021, then soared by 51.79% to $85000.0 in 2022, then advanced by 14.12% to $97000.0 in 2023, then fell by 1.03% to $96000.0 in 2024, then plunged by 123.96% to -$23000.0 in 2025.
- The last three Share-based Compensation figures came in at -$23000.0 (Q4 2025), $383000.0 (Q3 2025), and $687000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 288,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | 383,000.00 |
| Sep 30, 2025 | 383,000.00 |
| Jun 30, 2025 | 687,000.00 |
| Jun 30, 2025 | 687,000.00 |
| Mar 31, 2025 | 715,000.00 |
| Mar 31, 2025 | 715,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 255,000.00 |
| Sep 30, 2024 | 255,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 29,000.00 |